ProxyBio
Guangming
About ProxyBio
ProxyBio develops treatment and pharmaceutical products for mRNA development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Last round: Series Unknown (Jan 2023)
- Website: proxybiotec.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/proxybio-3021207 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.